ANIP peer analysis
ANI Pharmaceuticals (ANIP) against its competitors: price, today's move, 1-year return and market value side by side.
ANIP and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | $27.12 | 0.33% | 6.35% | $1.15B |
| AMRX Amneal | $20.22 | -1.08% | 86.88% | $7.12B |
| BHC Bausch Health | $8.13 | 1.37% | 15.81% | $3.00B |
| COLL Collegium | $23.75 | 0.30% | -34.03% | $770.92M |
| EOLS Evolus | $7.39 | 3.28% | 14.47% | $472.92M |
| HROW Harrow | $28.53 | 1.17% | -24.46% | $1.06B |
| LFCR Lifecore Biomedical | $6.42 | 0.55% | -10.64% | – |
| RDY Dr. Reddy's Laboratories | $14.30 | 1.20% | 7.60% | $11.77B |
| TEVA Teva | $41.94 | 3.05% | 104.79% | $47.47B |
| VTRS Viatris | $18.81 | 0.75% | 81.56% | – |
| ANIP ANI Pharmaceuticals | $72.19 | 2.15% | -20.32% | $1.62B |
- ANIP's peers: AMPH (Amphastar Pharmaceuticals), AMRX (Amneal), BHC (Bausch Health), COLL (Collegium), EOLS (Evolus), HROW (Harrow), LFCR (Lifecore Biomedical), RDY (Dr. Reddy's Laboratories).
Updated 2026-11-04 02:04 UTC